August 1, 2024- Henry Schein, Inc. released its 2023 CARES Report on Sustainability and Corporate Citizenship. Henry Schein Cares, our global corporate citizenship program, aims to drive positive change through its five pillars: Catalyzing health care access; Advancing policies, solutions and innovation; Relationship-building for change; Empowering Team Schein; and Sustaining … [Read more...]
SAMHSA releases annual national survey on drug use and health
August 1, 2024- The U.S. Department of Health and Human Services' (HHS) Substance Abuse and Mental Health Services Administration (SAMHSA) released the results of the 2023 National Survey on Drug Use and Health (NSDUH), which shows how people living in United States reported their experience with mental health conditions, substance use and pursuit of treatment. The 2023 … [Read more...]
Intermountain Health opens solar farm to supply green energy to its hospitals and clinics
August 1, 2024- Intermountain Health is celebrating a major advancement in its sustainability efforts with the opening of the Castle Solar Farm in Huntington, UT, which will provide power for several Intermountain hospitals, clinics, and other facilities and result in a cost savings of more than $500,000 annually. The 40-megawatt solar farm, which Intermountain Health has … [Read more...]
Teleflex receives FDA 510(k) clearance of the Ringer™ Perfusion Balloon Catheter
August 1, 2024- Teleflex Incorporated announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Ringer™ Perfusion Balloon Catheter (PBC), the only commercially available Percutaneous Transluminal Coronary Angioplasty (PTCA) perfusion balloon. The Ringer™ PBC is a rapid-exchange 0.014” compatible catheter with a unique helical balloon at its working end. When … [Read more...]
Community Health Systems announces definitive agreement to sell three Pennsylvania Hospitals to WoodBridge Healthcare Inc.
August 1, 2024- Community Health Systems, Inc. announced that certain subsidiaries of the Company have entered into a definitive agreement to sell three Pennsylvania hospitals – 186-bed Regional Hospital of Scranton and 122-bed Moses Taylor Hospital in Scranton, 369-bed Wilkes-Barre General Hospital in Wilkes-Barre, and certain related businesses to affiliates of WoodBridge … [Read more...]
HealthTrust Performance Group announces executive appointments
July 31, 2024- HealthTrust Performance Group announced two executive appointments. Guy W. Wagner has been promoted to senior vice president of strategic sourcing. Wagner joined HealthTrust in 2014 and most recently served as vice president of strategic sourcing for commercial products and services. In this role, Wagner will oversee strategic sourcing and distribution of GPO … [Read more...]
Cleveland Clinic names first Chief AI Officer
July 31, 2024- Cleveland Clinic has appointed its first Chief Artificial Intelligence Officer to direct the use of AI across the health system. Ben Shahshahani, Ph.D., a technology executive with more than 20 years of experience in AI and machine learning, will serve as Vice President, Chief Artificial Intelligence Officer, starting Aug. 12, 2024. He will report to Chief … [Read more...]
Thermo Fisher Scientific announces extended 510k clearance of Freelite Assays
July 31, 2024- Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has been 510k cleared, following US Food and Drug Administration (FDA) requirements, to market its Optilite® Freelite® assays’ claim for the evaluation of monoclonal gammopathy of undetermined significance (MGUS). MGUS affects an estimated 3% of the U.S. population over 50 and … [Read more...]
Vizient projects drug price inflation at 3.81%
July 31, 2024- Vizient, Inc. released its summer Pharmacy Market Outlook estimating the 2025 overall drug price inflation rate for pharmaceuticals at 3.81% based in part on expanding indications of previously approved medications, such as semaglutide, which increased 77% in spend since the summer 2023 Outlook. The report also urges providers to prepare for an increased number … [Read more...]
Teleflex awarded Hemostasis Products Agreements with Premier, Inc.
July 31, 2024- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with Premier, Inc. Effective July 1, 2024, the Premier National Hemostasis Products and SURPASS® Hemostasis Products agreements allow Premier members, at their discretion, to take advantage of special pricing and … [Read more...]